Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022) - Concepedia

Concepedia

Publication | Open Access

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)

DOI Full Paper Access

33

Citations

23

References

2023

Year

Jialing Lin, Sallie‐Anne Pearson, Jerry R. Greenfield, Kyeong Hye Park, Alys Havard, David Brieger, Richard O. Day, Michael O. Falster, Juliana de Oliveira Costa

European Journal of Clinical Pharmacology

References

	Year	Citations

Page 1